These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15109023)

  • 61. Nanosizing: a formulation approach for poorly-water-soluble compounds.
    Merisko-Liversidge E; Liversidge GG; Cooper ER
    Eur J Pharm Sci; 2003 Feb; 18(2):113-20. PubMed ID: 12594003
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nanoparticle layers controlling drug release from emulsions.
    Simovic S; Prestidge CA
    Eur J Pharm Biopharm; 2007 Aug; 67(1):39-47. PubMed ID: 17329085
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nanosizing of drugs: Effect on dissolution rate.
    Dizaj SM; Vazifehasl Zh; Salatin S; Adibkia Kh; Javadzadeh Y
    Res Pharm Sci; 2015; 10(2):95-108. PubMed ID: 26487886
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Review: Pharmaceutical and Pharmacokinetic Aspect of Nanocrystalline Suspensions.
    Shah DA; Murdande SB; Dave RH
    J Pharm Sci; 2016 Jan; 105(1):10-24. PubMed ID: 26580860
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An investigation into the mechanism of dissolution rate enhancement of poorly water-soluble drugs from spray chilled gelucire 50/13 microspheres.
    Qi S; Marchaud D; Craig DQ
    J Pharm Sci; 2010 Jan; 99(1):262-74. PubMed ID: 19653284
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhancement of the dissolution rate of a poorly water-soluble drug (tolbutamide) by a spray-drying solvent deposition method and disintegrants.
    Takeuchi H; Handa T; Kawashima Y
    J Pharm Pharmacol; 1987 Oct; 39(10):769-73. PubMed ID: 2891813
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drug nanocrystals - Versatile option for formulation of poorly soluble materials.
    Peltonen L; Hirvonen J
    Int J Pharm; 2018 Feb; 537(1-2):73-83. PubMed ID: 29262301
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lipid-based formulations for oral administration of poorly water-soluble drugs.
    Mu H; Holm R; Müllertz A
    Int J Pharm; 2013 Aug; 453(1):215-24. PubMed ID: 23578826
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Co-amorphous systems for the delivery of poorly water-soluble drugs: recent advances and an update.
    Han J; Wei Y; Lu Y; Wang R; Zhang J; Gao Y; Qian S
    Expert Opin Drug Deliv; 2020 Oct; 17(10):1411-1435. PubMed ID: 32683996
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs.
    Rasenack N; Müller BW
    Pharm Res; 2002 Dec; 19(12):1894-900. PubMed ID: 12523671
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Application of hot melt extrusion for poorly water-soluble drugs: limitations, advances and future prospects.
    Lu M; Guo Z; Li Y; Pang H; Lin L; Liu X; Pan X; Wu C
    Curr Pharm Des; 2014; 20(3):369-87. PubMed ID: 23651401
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Strategies to address low drug solubility in discovery and development.
    Williams HD; Trevaskis NL; Charman SA; Shanker RM; Charman WN; Pouton CW; Porter CJ
    Pharmacol Rev; 2013 Jan; 65(1):315-499. PubMed ID: 23383426
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oral lipid-based formulations.
    Hauss DJ
    Adv Drug Deliv Rev; 2007 Jul; 59(7):667-76. PubMed ID: 17618704
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of nucleation kinetics of poorly water-soluble drugs in presence of ultrasound and hydroxypropyl methyl cellulose during antisolvent precipitation.
    Dalvi SV; Dave RN
    Int J Pharm; 2010 Mar; 387(1-2):172-9. PubMed ID: 20026199
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Surfactant-Free Solid Dispersions of Hydrophobic Drugs in an Amorphous Sugar Matrix Dried from an Organic Solvent.
    Takeda K; Gotoda Y; Hirota D; Hidaka F; Sato T; Matsuura T; Imanaka H; Ishida N; Imamura K
    Mol Pharm; 2017 Mar; 14(3):791-798. PubMed ID: 28192663
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs.
    McNamara DP; Whitney KM; Goss SL
    Pharm Res; 2003 Oct; 20(10):1641-6. PubMed ID: 14620520
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of nanosizing on solubility and dissolution rate of poorly soluble pharmaceuticals.
    Murdande SB; Shah DA; Dave RH
    J Pharm Sci; 2015 Jun; 104(6):2094-2102. PubMed ID: 25821105
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
    Vasconcelos T; Sarmento B; Costa P
    Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.